CTI's PETNet Solutions signs two collaboration agreements

TriMed Staff | | Health Imaging | Molecular Imaging
CTI Molecular Imaging Inc. subsidiary PETNet Solutions this week signed partnership pacts with Johns Hopkins Healthcare (JHHC) and the Yerkes National Primate Research Center of Emory University.

PETNet will partner with JHHC on the management of the production and distribution of clinical positron emission tomography (PET) radiopharmaceuticals produced at JHHC's PET cyclotron production facility. PETNet will manage the existing production facility and supply PET isotopes to the nearby market, as well as help support some of Johns Hopkins' existing PET clinical and research programs.

PETNet's alliance with Yerkes is on the research and development of new PET molecular probes. Yerkes and PETNet will operate a pre-clinical research site at Yerkes' new neuroscience building, scheduled to open this fall. PETNet additionally will locate a production facility at Yerkes to supply PET isotopes for clinical and research needs, including those at the Yerkes Research Center.

TriMed Staff

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup